Quantitative assessment of the CD26+ leukemic stem cell compartment in chronic myeloid leukemia: patient-subgroups, prognostic impact, and technical aspects.
about
Expression of CD25 on leukemic stem cells in BCR-ABL1+ CML: Potential diagnostic value and functional implications.FOXM1 Transcription Factor: A New Component of Chronic Myeloid Leukemia Stem Cell Proliferation Advantage.ADAM8 Is an Antigen of Tyrosine Kinase Inhibitor-Resistant Chronic Myeloid Leukemia Cells Identified by Patient-Derived Induced Pluripotent Stem Cells.Targeting Leukemia Stem Cells in the Bone Marrow Niche.Residual Peripheral Blood CD26+ Leukemic Stem Cells in Chronic Myeloid Leukemia Patients During TKI Therapy and During Treatment-Free Remission.Targeting the Extracellular Signal-Regulated Kinase 5 Pathway to Suppress Human Chronic Myeloid Leukemia Stem Cells
P2860
Quantitative assessment of the CD26+ leukemic stem cell compartment in chronic myeloid leukemia: patient-subgroups, prognostic impact, and technical aspects.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Quantitative assessment of the ...... impact, and technical aspects.
@en
Quantitative assessment of the ...... impact, and technical aspects.
@nl
type
label
Quantitative assessment of the ...... impact, and technical aspects.
@en
Quantitative assessment of the ...... impact, and technical aspects.
@nl
prefLabel
Quantitative assessment of the ...... impact, and technical aspects.
@en
Quantitative assessment of the ...... impact, and technical aspects.
@nl
P2093
P2860
P50
P356
P1433
P1476
Quantitative assessment of the ...... impact, and technical aspects
@en
P2093
Barbora Weinbergerova
Dana Dvorakova
Daniela Zackova
Filip Razga
Jiri Mayer
Jiri Smejkal
Lukas Semerad
Marek Borsky
Martin Culen
Tomas Jurcek
P2860
P304
33016-33024
P356
10.18632/ONCOTARGET.9108
P407
P577
2016-05-01T00:00:00Z